• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双胎妊娠中通过孕妇血液游离DNA分析进行非整倍体筛查的性能

Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies.

作者信息

Bevilacqua E, Gil M M, Nicolaides K H, Ordoñez E, Cirigliano V, Dierickx H, Willems P J, Jani J C

机构信息

Department of Obstetrics and Gynecology, University Hospital Brugmann, Brussels, Belgium.

出版信息

Ultrasound Obstet Gynecol. 2015 Jan;45(1):61-6. doi: 10.1002/uog.14690. Epub 2014 Dec 4.

DOI:10.1002/uog.14690
PMID:25297464
Abstract

OBJECTIVES

To report clinical implementation of cell-free DNA (cfDNA) analysis of maternal blood in screening for trisomies 21, 18 and 13 in twin pregnancies and examine variables that could influence the failure rate of the test.

METHODS

cfDNA testing was performed in 515 twin pregnancies at 10-28 weeks' gestation. The failure rate of the test to provide results was compared with that in 1847 singleton pregnancies, and logistic regression analysis was used to determine which factors among maternal and pregnancy characteristics were significant predictors of test failure.

RESULTS

Failure rate of the cfDNA test at first sampling was 1.7% in singletons and 5.6% in twins. Of those with a test result, the median fetal fraction in twins was 8.7% (range, 4.1-30.0%), which was lower than that in singletons (11.7% (range, 4.0-38.9%)). Multivariable regression analysis demonstrated that twin pregnancy, higher maternal weight and conception by in-vitro fertilization provided significant independent prediction of test failure. Follow-up was available in 351 (68.2%) of the twin pregnancies and comprised 334 with euploid fetuses, 12 discordant for trisomy 21 and five discordant for trisomy 18. In all 323 euploid cases with a result, the risk score for each trisomy was < 1:10 000. In 11 of the 12 cases with trisomy 21 and in the five with trisomy 18, the cfDNA test gave a high-risk result, but in one case of trisomy 21, the score was < 1:10 000.

CONCLUSION

In twin pregnancies screening by cfDNA testing is feasible, but the failure rate is higher and detection rate may be lower than in singletons.

摘要

目的

报告孕妇外周血游离DNA(cfDNA)分析在双胎妊娠21、18和13三体综合征筛查中的临床应用情况,并探讨可能影响检测失败率的因素。

方法

对515例妊娠10 - 28周的双胎妊娠进行cfDNA检测。将该检测结果未得出的失败率与1847例单胎妊娠的情况进行比较,并采用逻辑回归分析确定孕产妇和妊娠特征中的哪些因素是检测失败的显著预测指标。

结果

单胎妊娠首次采样时cfDNA检测的失败率为1.7%,双胎妊娠为5.6%。在获得检测结果的人群中,双胎妊娠的胎儿游离DNA比例中位数为8.7%(范围4.1% - 30.0%),低于单胎妊娠(11.7%(范围4.0% - 38.9%))。多变量回归分析表明,双胎妊娠、孕产妇体重较高以及体外受精受孕是检测失败的显著独立预测因素。351例(68.2%)双胎妊娠有随访结果,其中334例胎儿为整倍体,12例21三体不一致,5例18三体不一致。在所有323例有结果的整倍体病例中,每种三体的风险评分均<1:10000。在12例21三体病例中的11例以及5例18三体病例中,cfDNA检测给出了高风险结果,但1例21三体病例的评分<1:10000。

结论

在双胎妊娠中,通过cfDNA检测进行筛查是可行的,但失败率较高,且检测率可能低于单胎妊娠。

相似文献

1
Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies.双胎妊娠中通过孕妇血液游离DNA分析进行非整倍体筛查的性能
Ultrasound Obstet Gynecol. 2015 Jan;45(1):61-6. doi: 10.1002/uog.14690. Epub 2014 Dec 4.
2
Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.双胎妊娠孕妇母体外周血游离 DNA 检测行早孕期唐氏综合征筛查的前瞻性研究。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):705-11. doi: 10.1002/uog.15913. Epub 2016 Apr 27.
3
Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies.母体外周血游离 DNA 检测在非整倍体早期筛查中的应用。
Ultrasound Obstet Gynecol. 2013 Jul;42(1):34-40. doi: 10.1002/uog.12504. Epub 2013 Jun 7.
4
First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.早孕期母体外周血游离 DNA 筛查唐氏综合征:影响检测失败的因素。
Ultrasound Obstet Gynecol. 2019 Jun;53(6):804-809. doi: 10.1002/uog.20290.
5
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.孕10 - 11周时通过母体血液游离DNA分析筛查21 -三体、18 -三体和13 -三体,以及孕11 - 13周时进行联合检测。
Ultrasound Obstet Gynecol. 2015 Jan;45(1):36-41. doi: 10.1002/uog.14664. Epub 2014 Nov 20.
6
UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptake.英国国民健康服务体系关于游离DNA检测用于胎儿三体综合征筛查的试点研究:影响接受率的因素
Ultrasound Obstet Gynecol. 2015 Jan;45(1):67-73. doi: 10.1002/uog.14683. Epub 2014 Nov 24.
7
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.英国国民医疗服务体系(NHS)中胎儿三体综合征常规筛查的临床实施:基于孕早期联合检测结果的游离DNA检测
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52. doi: 10.1002/uog.15783. Epub 2015 Oct 26.
8
Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.母体血液游离 DNA 检测筛查双胎妊娠非整倍体:胎儿医学基金会研究结果及荟萃分析更新。
Ultrasound Obstet Gynecol. 2019 Jun;53(6):734-742. doi: 10.1002/uog.20284. Epub 2019 Jun 4.
9
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.双胎妊娠胎儿三体的常规早孕期筛查:游离 DNA 检测取决于联合检测的结果。
Ultrasound Obstet Gynecol. 2019 Feb;53(2):208-213. doi: 10.1002/uog.20160. Epub 2018 Dec 7.
10
Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies.孕早期双胎妊娠中用于三体风险评估的游离DNA分析
Fetal Diagn Ther. 2014;35(3):204-11. doi: 10.1159/000356495. Epub 2013 Nov 15.

引用本文的文献

1
ISUOG Practice Guidelines (updated): role of ultrasound in twin pregnancy.国际妇产科超声学会(ISUOG)实践指南(更新版):超声在双胎妊娠中的作用
Ultrasound Obstet Gynecol. 2025 Feb;65(2):253-276. doi: 10.1002/uog.29166. Epub 2025 Jan 15.
2
A Decade of Non-Invasive Prenatal Testing (NIPT) for Chromosomal Abnormalities in Croatia: First National Monocentric Study to Inform Country's Future Prenatal Care Strategy.克罗地亚十年无创产前检测(NIPT)用于染色体异常检测:为该国未来产前护理策略提供信息的首个全国单中心研究
Genes (Basel). 2024 Dec 11;15(12):1590. doi: 10.3390/genes15121590.
3
Counselling in Fetal Medicine: Uncomplicated Twin Pregnancies.
胎儿医学中的咨询:单绒双羊双胎妊娠
J Clin Med. 2024 Dec 3;13(23):7355. doi: 10.3390/jcm13237355.
4
Cell-free DNA screening in twin pregnancies.双胎妊娠中的游离DNA筛查。
Obstet Gynecol Sci. 2024 Mar;67(2):160-168. doi: 10.5468/ogs.23135. Epub 2024 Jan 25.
5
Maternal and Fetal Factors Affecting Cell-Free Fetal DNA (cffDNA) Fraction: A Systematic Review.影响游离胎儿DNA(cffDNA)比例的母胎因素:一项系统综述。
J Reprod Infertil. 2023 Oct-Dec;24(4):219-231. doi: 10.18502/jri.v24i4.14149.
6
Cell-Free Fetal DNA Screening Analysis in Korean Pregnant Women: Six Years of Experience and a Retrospective Study of 9327 Patients Analyzed from 2017 to 2022.韩国孕妇的游离胎儿DNA筛查分析:六年经验及对2017年至2022年分析的9327例患者的回顾性研究
J Pers Med. 2023 Oct 6;13(10):1468. doi: 10.3390/jpm13101468.
7
Assessment of a change of protocol of prenatal screening by inclusion of non-invasive prenatal diagnosis.通过纳入非侵入性产前诊断对产前筛查方案变更的评估。
Adv Lab Med. 2020 Apr 2;1(2):20200011. doi: 10.1515/almed-2020-0011. eCollection 2020 Jun.
8
Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis.影响孕妇游离胎儿 DNA 筛查中低胎儿分数的因素:系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2022 Dec 8;22(1):918. doi: 10.1186/s12884-022-05224-7.
9
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review.影响无创产前筛查中胎儿游离DNA比例的因素:综述
Front Pediatr. 2022 Jan 27;10:812781. doi: 10.3389/fped.2022.812781. eCollection 2022.
10
Performance of non-invasive prenatal testing for foetal chromosomal abnormalities in 1048 twin pregnancies.1048例双胎妊娠中胎儿染色体异常的无创产前检测性能
Mol Cytogenet. 2021 Jun 30;14(1):32. doi: 10.1186/s13039-021-00551-4.